Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Motion Sifnos: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness During Travel

Randomized, double-blind, placebo-controlled investigating the efficacy of tradipitant in the treatment of motion sickness.

Inclusion Criteria:

• Male or non-pregnant, non-lactating female patients aged 18 - 75 years (inclusive);
• Body Mass Index (BMI) of ≥18 and <40 kg/m2;
• History or symptoms consistent with motion sickness

Exclusion Criteria:

• Chronic nausea due to condition other than motion sickness;
• A positive test for drugs of abuse at the screening or evaluation visits;
• Clinically significant deviation from normal clinical laboratory results